The NEOS Bitcoin High Income ETF (BTCI) offers a 25.61% distribution rate by using an options strategy on Bitcoin ETFs, despite Bitcoin itself paying no dividends or income. BTCI generates income by selling options that command high premiums due to Bitcoin's volatility, converting this risk into cash flow. However, the ETF has lagged the S&P Bitcoin Index in total returns, partly due to fees and giving up some upside potential. This strategy suits income-focused investors but may not be ideal for those seeking long-term Bitcoin growth.
The NEOS Bitcoin High Income ETF's yield strategy is notable for its 25.61% distribution rate despite Bitcoin paying no dividends. For readers following the broader US stock market, here is Pluang's market snapshot as of Oct 02, 2026 02:41 WIB: out of 150 priced US stocks tradable on Pluang, 83 rose and 65 fell. Notable movers include AMAT at USD 530.59 with a 3.76% increase and 86% sell order activity, LCID at USD 4.22 with a 3.69% increase and 97% buy order activity, and ZM at USD 94.00 with a 3.55% increase and 100% sell order activity.
Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...
RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report ...
Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...
